Cargando…

La enfermedad de Huntington en la Comunitat Valenciana

INTRODUCTION. Huntington disease (HD) is a rare neurodegenerative disorder of the central nervous system characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia. OBJECTIVE. Describe the geographical, age and sex distribution of HD in the Valencia Region (V...

Descripción completa

Detalles Bibliográficos
Autores principales: Páramo-Rodríguez, Lucía, Moreno-Marro, Sandra, Guardiola-Vilarroig, Sandra, Zurriaga, Óscar, Cavero-Carbonell, Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Viguera Editores (Evidenze Group) 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478134/
https://www.ncbi.nlm.nih.gov/pubmed/37231547
http://dx.doi.org/10.33588/rn.7611.2022088
_version_ 1785101281290878976
author Páramo-Rodríguez, Lucía
Moreno-Marro, Sandra
Guardiola-Vilarroig, Sandra
Zurriaga, Óscar
Cavero-Carbonell, Clara
author_facet Páramo-Rodríguez, Lucía
Moreno-Marro, Sandra
Guardiola-Vilarroig, Sandra
Zurriaga, Óscar
Cavero-Carbonell, Clara
author_sort Páramo-Rodríguez, Lucía
collection PubMed
description INTRODUCTION. Huntington disease (HD) is a rare neurodegenerative disorder of the central nervous system characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia. OBJECTIVE. Describe the geographical, age and sex distribution of HD in the Valencia Region (VR) and determine its prevalence and mortality. MATERIALS AND METHODS. Cross-sectional study for the period 2010-2018. Confirmed cases of HD were identified through the Rare Disease Information System of the VR. Sociodemographic characteristics were described, and the prevalence and mortality rate were obtained. RESULTS. 225 cases were identified, 50.2% women. 52.0% lived in the province of Alicante. 68.9% were verified by their clinical diagnosis. The median age at diagnosis was 54.1 years, 54.7 years in men and 53.0 years in women. The prevalence in 2018 was 1.97/100,000 inhabitants (95%; CI: 0.39-2.37), showing a no significant increasing trend, overall and by sex. 49.8% died, 51.8% men. The median age at death was 62.7 years, being lower in men than in women. The mortality rate in 2018 was 0.32/100,000 inhabitants (95%; CI: 0.32-2.28), with no statistically significant differences. CONCLUSIONS. The prevalence obtained was within the range estimated by Orphanet (1-9/100,000). A difference between sexes was observed in the diagnosis age. Men are the group with the highest mortality and the earliest age of death. It is a disease with high mortality with an average of 6.5 years between diagnosis and death.
format Online
Article
Text
id pubmed-10478134
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Viguera Editores (Evidenze Group)
record_format MEDLINE/PubMed
spelling pubmed-104781342023-09-06 La enfermedad de Huntington en la Comunitat Valenciana Páramo-Rodríguez, Lucía Moreno-Marro, Sandra Guardiola-Vilarroig, Sandra Zurriaga, Óscar Cavero-Carbonell, Clara Rev Neurol Original INTRODUCTION. Huntington disease (HD) is a rare neurodegenerative disorder of the central nervous system characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia. OBJECTIVE. Describe the geographical, age and sex distribution of HD in the Valencia Region (VR) and determine its prevalence and mortality. MATERIALS AND METHODS. Cross-sectional study for the period 2010-2018. Confirmed cases of HD were identified through the Rare Disease Information System of the VR. Sociodemographic characteristics were described, and the prevalence and mortality rate were obtained. RESULTS. 225 cases were identified, 50.2% women. 52.0% lived in the province of Alicante. 68.9% were verified by their clinical diagnosis. The median age at diagnosis was 54.1 years, 54.7 years in men and 53.0 years in women. The prevalence in 2018 was 1.97/100,000 inhabitants (95%; CI: 0.39-2.37), showing a no significant increasing trend, overall and by sex. 49.8% died, 51.8% men. The median age at death was 62.7 years, being lower in men than in women. The mortality rate in 2018 was 0.32/100,000 inhabitants (95%; CI: 0.32-2.28), with no statistically significant differences. CONCLUSIONS. The prevalence obtained was within the range estimated by Orphanet (1-9/100,000). A difference between sexes was observed in the diagnosis age. Men are the group with the highest mortality and the earliest age of death. It is a disease with high mortality with an average of 6.5 years between diagnosis and death. Viguera Editores (Evidenze Group) 2023-06-01 /pmc/articles/PMC10478134/ /pubmed/37231547 http://dx.doi.org/10.33588/rn.7611.2022088 Text en Copyright: © Revista de Neurología https://creativecommons.org/licenses/by-nc-nd/4.0/Revista de Neurología trabaja bajo una licencia Creative Commons
spellingShingle Original
Páramo-Rodríguez, Lucía
Moreno-Marro, Sandra
Guardiola-Vilarroig, Sandra
Zurriaga, Óscar
Cavero-Carbonell, Clara
La enfermedad de Huntington en la Comunitat Valenciana
title La enfermedad de Huntington en la Comunitat Valenciana
title_full La enfermedad de Huntington en la Comunitat Valenciana
title_fullStr La enfermedad de Huntington en la Comunitat Valenciana
title_full_unstemmed La enfermedad de Huntington en la Comunitat Valenciana
title_short La enfermedad de Huntington en la Comunitat Valenciana
title_sort la enfermedad de huntington en la comunitat valenciana
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478134/
https://www.ncbi.nlm.nih.gov/pubmed/37231547
http://dx.doi.org/10.33588/rn.7611.2022088
work_keys_str_mv AT paramorodriguezlucia laenfermedaddehuntingtonenlacomunitatvalenciana
AT morenomarrosandra laenfermedaddehuntingtonenlacomunitatvalenciana
AT guardiolavilarroigsandra laenfermedaddehuntingtonenlacomunitatvalenciana
AT zurriagaoscar laenfermedaddehuntingtonenlacomunitatvalenciana
AT caverocarbonellclara laenfermedaddehuntingtonenlacomunitatvalenciana